期刊
CLINICS IN PERINATOLOGY
卷 42, 期 3, 页码 557-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.clp.2015.04.016
关键词
Anemia; Transfusions; Neuroprotection; Neurodevelopment; Darbepoetin; Erythropoiesis-stimulating agents
资金
- Thrasher Research Fund
- NIH [R01HD059856]
Erythropoiesis-stimulating agents (ESAs) such as erythropoietin have been studied as red cell growth factors in preterm and term infants for more than 20 years. Recent studies have evaluated darbepoetin (Darbe, a long-acting ESA) for both erythropoietic effects and potential neuroprotection. We review clinical trials of Darbe in term and preterm infants, which have reported significant erythropoietic uses and neuroprotective effects. ESAs show great promise in decreasing or eliminating transfusions, and in preventing and treating brain injury in term and preterm infants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据